罗氏求助于数字营销以提高患者对其减肥药的依从性。
Roche turns to DM to boost patient compliance with its weight loss drug.
出版信息
Dis Manag Advis. 2002 Apr;8(4):51-4, 49.
PMID:11995433
Abstract
It can be tough getting patients to take their medicines as prescribed, particularly when there are side-effects or other barriers involved. To get around this problem, Roche decided to develop a DM approach to guide patients taking the organization's new weight-loss agent, XENICAL. In place now for 15 months, the telephonic program is boosting compliance and getting the intended results.
摘要
让患者按规定服药可能会很困难，尤其是当涉及副作用或其他障碍时。为了解决这个问题，罗氏公司决定开发一种直接面向消费者（DM）的方法，以指导患者服用该公司的新型减肥药物赛尼可。这个电话项目已经实施了15个月，正在提高患者的依从性并取得预期效果。
Zotero 插件